Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| AIDS Dementia Complex | 7 | 1997 | 154 | 0.280 |
Why?
|
| HIV-1 | 6 | 1996 | 6939 | 0.070 |
Why?
|
| HIV Seropositivity | 4 | 1997 | 971 | 0.070 |
Why?
|
| Reaction Time | 1 | 1993 | 2098 | 0.070 |
Why?
|
| Choline | 2 | 1997 | 493 | 0.060 |
Why?
|
| Outpatients | 1 | 2011 | 1487 | 0.060 |
Why?
|
| Panic Disorder | 2 | 1995 | 616 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 1993 | 6994 | 0.050 |
Why?
|
| Gene Products, env | 2 | 1996 | 263 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2001 | 865 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1993 | 1821 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2001 | 956 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 1996 | 952 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 2 | 1993 | 535 | 0.030 |
Why?
|
| HIV Antigens | 1 | 1993 | 347 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1996 | 1154 | 0.030 |
Why?
|
| Epilepsies, Partial | 1 | 1995 | 436 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2011 | 6598 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2001 | 2684 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 1681 | 0.020 |
Why?
|
| Computers | 1 | 1993 | 612 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 1993 | 1107 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1997 | 1406 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 1996 | 1322 | 0.020 |
Why?
|
| Cocaine | 1 | 1992 | 1007 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1992 | 1607 | 0.020 |
Why?
|
| Brain | 6 | 1996 | 26388 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2001 | 4255 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1994 | 2036 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2011 | 6036 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1993 | 1563 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1993 | 1916 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1995 | 6151 | 0.010 |
Why?
|
| HIV Infections | 3 | 2001 | 16715 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6366 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2011 | 1642 | 0.010 |
Why?
|
| Adult | 10 | 2011 | 214052 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2011 | 1644 | 0.010 |
Why?
|
| Cytokines | 1 | 1993 | 7323 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 14723 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1993 | 1382 | 0.010 |
Why?
|
| Blotting, Western | 2 | 1996 | 5181 | 0.010 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 1996 | 16 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1996 | 99 | 0.010 |
Why?
|
| Epitopes | 2 | 1993 | 2571 | 0.010 |
Why?
|
| Male | 10 | 2011 | 350115 | 0.010 |
Why?
|
| Self Care | 1 | 2001 | 786 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1992 | 4257 | 0.010 |
Why?
|
| Middle Aged | 8 | 2001 | 213390 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2001 | 8319 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1993 | 5027 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 1997 | 35425 | 0.010 |
Why?
|
| Absorption | 1 | 1994 | 248 | 0.010 |
Why?
|
| Creatine | 1 | 1996 | 421 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1996 | 576 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1993 | 98 | 0.010 |
Why?
|
| Gene Products, nef | 1 | 1992 | 110 | 0.010 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1992 | 68 | 0.010 |
Why?
|
| Clonazepam | 1 | 1993 | 136 | 0.010 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 1992 | 153 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1993 | 258 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1157 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1992 | 137 | 0.010 |
Why?
|
| Female | 7 | 2011 | 380193 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1992 | 248 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 1995 | 355 | 0.010 |
Why?
|
| Carbamazepine | 1 | 1993 | 229 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 1992 | 337 | 0.010 |
Why?
|
| Humans | 13 | 2011 | 744366 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1994 | 1095 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 574 | 0.010 |
Why?
|
| Blood Cells | 1 | 1993 | 309 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1993 | 13814 | 0.010 |
Why?
|
| Oximes | 1 | 1992 | 311 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 63107 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1993 | 18111 | 0.010 |
Why?
|
| Clone Cells | 1 | 1993 | 1692 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 931 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1992 | 1369 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1992 | 1880 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 3759 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1993 | 3207 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 6621 | 0.000 |
Why?
|
| Aged | 2 | 1993 | 163288 | 0.000 |
Why?
|
| Radiography | 1 | 1993 | 7023 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1993 | 4424 | 0.000 |
Why?
|
| Seizures | 1 | 1993 | 2859 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 12961 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1993 | 4666 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 16000 | 0.000 |
Why?
|
| Multiple Sclerosis | 1 | 1994 | 3079 | 0.000 |
Why?
|
| Proteins | 1 | 1994 | 6100 | 0.000 |
Why?
|
| Risk Factors | 1 | 2001 | 72296 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1993 | 77460 | 0.000 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_